Investor Relations

The press releases contained in this archive section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. PTC Therapeutics disavows any obligation to update the information contained in such press releases after the date of their issuance.


All Releases
View Summary PTC Therapeutics Receives Conditional Approval in the European Union for Translarna For the Treatment of Nonsense Mutation Duchenne Muscular Dystrophy
Aug 4, 2014
PDF 11.2 KB Add to Briefcase
View Summary PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635©(4)
Aug 1, 2014
PDF 6.9 KB Add to Briefcase
View Summary PTC Therapeutics to Present at the Wedbush Life Sciences Management Access Conference
Jul 30, 2014
PDF 6.5 KB Add to Briefcase
View Summary PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2014 Financial Results
Jul 24, 2014
PDF 6.6 KB Add to Briefcase
View Summary PTC Therapeutics Announces Expanded Access Program For Translarna (ataluren)
Jul 9, 2014
PDF 10.4 KB Add to Briefcase
View Summary PTC THERAPEUTICS INITIATES CONFIRMATORY PHASE 3 CLINICAL TRIAL OF TRANSLARNA (ATALUREN) IN PATIENTS WITH NONSENSE MUTATION CYSTIC FIBROSIS (NMCF)
Jun 30, 2014
PDF 11.7 KB Add to Briefcase
View Summary PTC THERAPEUTICS RECIPIENT OF PARENT PROJECT MUSCULAR DYSTROPHY'S "PATH TO PROGRESS" AWARD
Jun 30, 2014
PDF 8.6 KB Add to Briefcase
View Summary PTC THERAPEUTICS TO PRESENT AT THE 9TH ANNUAL JMP SECURITIES HEALTHCARE CONFERENCE
Jun 17, 2014
PDF 6.5 KB Add to Briefcase
View Summary SHANE KOVACS RECEIVES THE 2014 NEW JERSEY TECHNOLOGY COUNCIL CFO - DEAL OF THE YEAR AWARD
Jun 13, 2014
PDF 10.1 KB Add to Briefcase
View Summary PTC THERAPEUTICS APPOINTS RONALD C. RENAUD, JR. TO BOARD OF DIRECTORS
Jun 11, 2014
PDF 8.4 KB Add to Briefcase
View Summary PTC THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635©(4)
Jun 10, 2014
PDF 6.9 KB Add to Briefcase
View Summary PTC Therapeutics Provides EMA Update
May 23, 2014
PDF 6.6 KB Add to Briefcase
View Summary PTC THERAPEUTICS RECEIVES POSITIVE OPINION FROM CHMP FOR TRANSLARNA (ATALUREN)
May 23, 2014
PDF 14.3 KB Add to Briefcase
View Summary PTC Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference
May 21, 2014
PDF 6.4 KB Add to Briefcase
View Summary Ataluren Phase 3 Trial Results in Nonsense Mutation Cystic Fibrosis Published in The Lancet Respiratory Medicine
May 16, 2014
PDF 12.5 KB Add to Briefcase
View Summary PTC Therapeutics Reports First Quarter Financial Results and Provides Corporate Update
May 6, 2014
PDF 236.0 KB Add to Briefcase
View Summary PTC THERAPEUTICS TO PRESENT AT UPCOMING INVESTOR CONFERENCES
Apr 23, 2014
PDF 6.6 KB Add to Briefcase
View Summary PTC Therapeutics to Host Conference Call to Discuss First Quarter 2014 Financial Results
Apr 22, 2014
PDF 6.5 KB Add to Briefcase
View Summary PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635©(4)
Apr 21, 2014
PDF 6.8 KB Add to Briefcase
View Summary PTC Therapeutics Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Corporate Update
Mar 6, 2014
PDF 14.8 KB Add to Briefcase
Showing 21-40 of 96 Page: 1 2 3 4 5  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase